The Roivant Sciences dealmaking strategy revolutionising life sciences IP monetisation
A deep dive into the trail-blazing biopharma business established by former hedge fund partner Vivek Ramaswamy
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now